Results should be in the media somewhere but, what is important to PIQ is that PIQ is earning revenue from these trials of the Biosimilars that it has developed. The list of successfully developed Biosimilars by PIQ is growing. The revenue from the Lab. is about $2.7m, I think, and growing.
Potential revenue from PromarkerD: US $18m p.a for Spain alone.
PIQ Price at posting:
36.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)